UCB epilepsy drug wins FDA clearance
Keppra was previously approved in the US as adjunctive therapy for partial onset seizures in adults and children four years of age and older with epilepsy. The approval
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
The suite of solutions included irms|WM Warehouse Management and irms|EM Emergency Management, providing real-time visibility and accurate tracking of critical emergency supplies, people and processes. irms|WM facilitates a